Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
Ina‐Maria Rückert‐Eheberg, Michael Nolde, Nayeon Ahn, et al.
European Journal of Clinical Pharmacology (2021) Vol. 78, Iss. 4, pp. 657-667
Open Access | Times Cited: 23

Showing 23 citing articles:

Proton pump inhibitor use: systematic review of global trends and practices
L.G.T. Shanika, Andrew Reynolds, Sharon Pattison, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 9, pp. 1159-1172
Open Access | Times Cited: 93
Proton Pump Inhibitors and Bone Health: An Update Narrative Review
Éric Lespessailles, Hechmi Toumi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10733-10733
Open Access | Times Cited: 49
Proton Pump Inhibitors: Rational Use and Use-Reduction – The Windsor Workshop
Peter J. Kahrilas, Foteini Anastasiou, Albert J. Bredenoord, et al.
Digestive Diseases (2024) Vol. 42, Iss. 3, pp. 211-220
Open Access | Times Cited: 7
Gentamicin combination treatment is associated with lower mortality in patients with invasive listeriosis: a retrospective analysis
Jan P. Sutter, Lorenz Kocheise, Jan Kempski, et al.
Infection (2024) Vol. 52, Iss. 4, pp. 1601-1606
Open Access | Times Cited: 6
Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour
Sarah Wilkes, Kayleigh van de Wiel, Kelly Mulder, et al.
British Journal of Clinical Pharmacology (2025)
Open Access
Do proton pump inhibitors increase the risk of dementia? A systematic review, meta‐analysis and bias analysis
Nayeon Ahn, Michael Nolde, Evamaria Krause, et al.
British Journal of Clinical Pharmacology (2022) Vol. 89, Iss. 2, pp. 602-616
Open Access | Times Cited: 17
The Protease Inhibitor Amprenavir Protects against Pepsin-Induced Esophageal Epithelial Barrier Disruption and Cancer-Associated Changes
Simon Blaine‐Sauer, Tina L. Samuels, Ke Yan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6765-6765
Open Access | Times Cited: 10
Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany
Nayeon Ahn, Nina Wawro, Sebastian‐Edgar Baumeister, et al.
Drugs & Aging (2023) Vol. 40, Iss. 7, pp. 653-663
Closed Access | Times Cited: 8
Proton pump inhibitors and the risk of cardiovascular events and cardiovascular mortality: A systematic review and meta-analysis of observational studies
Michael Nolde, Nayeon Ahn, Tobias Dreischulte, et al.
European Journal of Internal Medicine (2022) Vol. 106, pp. 80-89
Open Access | Times Cited: 13
Sex-specific association of chronic proton pump inhibitor use with reduced bone density and quality
Fabio Bioletto, Alessia Pusterla, Federica Fraire, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 2
Inappropriate proton-pump inhibitor prescribing in primary care – an observational study with quality circles
Renata Vidonscky Lüthold, Nicole Christin Henz, Connor Fuhrer, et al.
Schweizerische medizinische Wochenschrift (2023) Vol. 153, Iss. 9, pp. 40119-40119
Open Access | Times Cited: 5
Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective Study Including 472 146 Patients
Kate Plehhova, Monika Haering, Joshua Wray, et al.
Journal of Primary Care & Community Health (2023) Vol. 14
Open Access | Times Cited: 5
Proton Pump Inhibitors in Germany: Status Quo of a Growing Market
Kate Plehhova, Monika Häring, Joshua Wray, et al.
Health Services Research and Managerial Epidemiology (2024) Vol. 11
Open Access | Times Cited: 1
Proton Pump Inhibitor Prescription in Nursing Home Residents: Prevalence, Appropriateness, and Associated Factors—A Secondary Data Analysis from Three German Regions and the Impact of Guideline Recommendations
Ursula Wolf, Martina Wegener
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1082-1082
Open Access | Times Cited: 1
Efficacy of a computer based discontinuation strategy to reduce PPI prescriptions: a multicenter cluster-randomized controlled trial
Julia Heisig, Bettina Bücker, Alexandra Schmidt, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Are integrated care models associated with improved drug safety in Swiss primary care? an observational analysis using healthcare claims data
Renato Farcher, Sereina M. Graber, Stefan Boes, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0311099-e0311099
Open Access
Proton pump inhibitors in inpatients: Are we getting it right? A retrospective analysis
Gowri Karuppasamy, Yousef Yahia, Jessiya Veliyankodan Parambil, et al.
Qatar medical journal (2024) Vol. 2024, Iss. 4
Open Access
Proton pump inhibitors – between use and abuse
Mihaela Udrescu
Medic ro (2024) Vol. 6, Iss. 162, pp. 38-38
Closed Access
Appropriateness of proton pump inhibitor therapy in an ambulatory geriatrics clinic: A retrospective cross-sectional analysis
Ryan Dixon, Jennifer Bolt
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (2023) Vol. 156, Iss. 6, pp. 331-336
Open Access | Times Cited: 1
Increased DNA content in stomach fluids: diagnostic implications of a possible new gastric cancer marker
Francine Carla Cadoná, Adriane Pelosof, Cláudia Zitron, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Do the benefits outweigh the risks? Potential dangers associated with long-term therapy of proton pump inhibitors
Izabela WOLANIN, Bartłomiej ZIELONKA, Barbara Dengler, et al.
Journal of Education Health and Sport (2023) Vol. 26, Iss. 1, pp. 63-80
Open Access
Missing PPI prescriptions while overprescribing?
Ingrid Schübert, Veronika Lappe, Ursula Marschall, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 11, pp. 1579-1581
Open Access
Medication Appropriateness among Older Persons Admitted to a General Hospital in Malaysia
Ker Sin Heng, Kit Mun Tan, Hui Min Khor, et al.
Malaysian Journal of Medicine and Health Sciences (2022) Vol. 18, Iss. 5, pp. 122-129
Open Access
Page 1

Scroll to top